US 12,458,530 B2
Cryogenic enhancement of joint function, alleviation of joint stiffness and/or alleviation of pain associated with osteoarthritis
Jwala Karnik, Santa Barbara, CA (US); Jason Reynolds, Santa Rosa, CA (US); John Allison, Los Altos, CA (US); and Clint Carnell, Park City, UT (US)
Assigned to Pacira CryoTech, Inc., Tampa, FL (US)
Filed by Pacira CryoTech, Inc., Parsippany, NJ (US)
Filed on Mar. 22, 2023, as Appl. No. 18/124,989.
Application 18/124,989 is a continuation of application No. 16/783,821, filed on Feb. 6, 2020, granted, now 11,642,241.
Application 16/783,821 is a continuation of application No. 15/454,762, filed on Mar. 9, 2017, granted, now 10,596,030, issued on Mar. 24, 2020.
Application 15/454,762 is a continuation of application No. 14/218,167, filed on Mar. 18, 2014, granted, now 9,610,112, issued on Apr. 4, 2017.
Application 14/218,167 is a continuation in part of application No. 14/025,527, filed on Sep. 12, 2013, granted, now 9,295,512, issued on Mar. 29, 2016.
Claims priority of provisional application 61/801,268, filed on Mar. 15, 2013.
Claims priority of provisional application 61/800,478, filed on Mar. 15, 2013.
Prior Publication US 2023/0218434 A1, Jul. 13, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61F 7/12 (2006.01); A61B 18/02 (2006.01); A61B 18/00 (2006.01); A61B 18/14 (2006.01); A61F 7/00 (2006.01); A61F 7/02 (2006.01)
CPC A61F 7/12 (2013.01) [A61B 18/02 (2013.01); A61B 2018/00041 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00565 (2013.01); A61B 2018/0212 (2013.01); A61B 2018/0262 (2013.01); A61B 2018/0293 (2013.01); A61B 2018/1425 (2013.01); A61F 2007/0063 (2013.01); A61F 2007/0093 (2013.01); A61F 2007/0096 (2013.01); A61F 2007/0285 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A system for reducing knee pain experienced by a patient, the system comprising:
a guide for identifying a treatment zone with reference to a skin surface of a patient, wherein the guide is configured to be placed on the skin surface of the patient relative to body landmarks; and
a treatment probe configured for directing a treatment under the skin surface with reference to the treatment zone identified by the guide, the treatment configured to modulate a nerve associated with pain of a knee of a leg.